Idamen 20mg/20ml Injection
Idarubicin hydrochloride
20mg/20ml
MUSTAFA NEVZAT ILAC SANAYII A.S.
| Pack size | 20ml Glass Vial |
|---|---|
| Dispensing mode | POM |
| Source | TURKEY |
| Agent | PHARMATRADE |
| Retail Price | 716.50 AED |
Available as:
Indications
Idamen 20mg/20ml Injection is used for:
For the treatment of acute myeloid leukemia (AML) in adults. This includes French-American-British (FAB) classifications M1 through M7.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Idarubicin hydrochloride :
Mechanism of Action
Idarubicin has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Idarubicin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes.
Note
Idamen 20mg/20ml 20mg/20ml Injection manufactured by MUSTAFA NEVZAT ILAC SANAYII A.S.. Its generic name is Idarubicin hydrochloride. Idamen 20mg/20ml is availble in United Arab Emirates.
Farmaco UAE drug index information on Idamen 20mg/20ml Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.